InvestorsHub Logo

The Market Maker

09/23/15 4:02 PM

#8567 RE: MinnieM #8559

Yep - Could be Hugh...

TwoPack

09/23/15 4:03 PM

#8568 RE: MinnieM #8559

Possibly UT Southwestern is not allowed to post such an estimation about ZoptEC, so they better removed the statement away from their site.
But it seems to me Zoptarelin-Doxorubicin could have worked fine for Southwestern patients while treating their patients during the study.

Thanks for the membermark
an GLTY with AEZS

Mac-A-Million

09/23/15 4:19 PM

#8573 RE: MinnieM #8559

Alot of us understand that the drug is an awesome thing~the controversy lies with dilution. Thats where everyone else does not want to tippy-toe! Any thoughts??

downtrendbuyer

09/23/15 4:40 PM

#8587 RE: MinnieM #8559

Does that not show that we are dealing with nasty and manipulative crooks...who else calls the hospital/Biotech comapny and requires that the last sentence must be removed. This has been pure manipulation so far and someone is feeling the heat as price was about to go higher than they expected/could allow.

Will be above $5